ICDS 2012  
Home arrow_breadcrumb Programme
Natisni print page  

Programme

Bellow you can now find some oral presentations and posters. They are published with permission of authors.

Oral presentations

Session 1           chair: Scott Weese

Miller M.

L1 - THE ROLE OF INFECTION CONTROL IN Clostridium difficile OUTBREAKS: THERE IS SO MUCH WE DON'T KNOW

Siu K.H.G. et al. (Yam W.C.)

01 - MOLECULAR EPIDEMIOLOGY OF Clostridium difficile IN HONG KONG

Indra A. et al.

O2 - HIGH OUTPUT PCR-RIBOTYPING OF Clostridium difficile DURING AN OUTBREAK OF PCR-RIBOTYPE 027 IN VIENNA, AUSTRIA IN 2009

Pillai D.R. et al.(Broukhanski G.)

O3 - DEFINING CRITERIA TO INTERPRET MULTI-LOCUS VARIABLE NUMBER TANDEM REPEAT ANALYSIS TO AID Clostridium difficile OUTBREAK INVESTIGATION

Session 2           chair: Bruno Dupuy

Kelly C.P.

L2 - HOST RESPONSE TO C. difficile INFECTION

Papatheodorou P. et al.

O4 - CLOSTRIDIAL GLUCOSYLATING TOXINS ENTER CELLS VIA CLATHRIN-MEDIATED ENDOCYTOSIS

Popoff M.R. and Geny B.

O5 - HOW DO LARGE CLOSTRIDIAL TOXINS MODIFY THE ACTIN CYTOSKELETON AND INTERCELLULAR JUNCTIONS AND ARE ALL CELLULAR EFFECTS DEPENDENT ON THEIR ENZYMATIC ACTIVITY ON SMALL GTPASES?

Miura M. et al.

O6 - A NOVEL VIRULENCE FACTOR SRL MODULATES TOXIN B SENSITIVITY OF INTESTINAL EPITHELIAL CELLS

Session 3           chair: Nigel Minton

 

Vedantam G.

L3 - Clostridium difficile PATHOGENESIS MEDIATED BY NON-TOXIN VIRULENCE FACTORS

 

Joshi L.T. et al.

07 - CHARACTERISATION OF THE SPORE SURFACE OF Clostridium difficile AND ITS ROLE IN ADHERENCE

 

Reynolds C. B. et al. (Fairweather N.F.)

08 - VARIATION AND CONSERVATION: THE REGULATION OF Clostridium difficile CELL WALL PROTEIN CWPV

Fortier L.C. et al.

O9 - THE MULTIPLE FACETS OF BACTERIOPHAGES AND THEIR ROLE IN THE DIVERSITY AND VIRULENCE OF C.  difficile

Session 4           chair: Glenn Songer

 

Buckley A. et al.

O10 - INFECTION WITH DIFFERENT TOXINOTYPE STRAINS OF Clostridium difficile RESULTS IN CLEAR PATHOLOGICAL DIFFERENCES IN THE HAMSTER MODEL

Zidaric V.et al.

O11 - PREVALENCE AND TYPING OF C. difficile IN A GROUP OF WHITE VEAL CALVES

Squire M.M. et al.

O12 - A NOVEL MOLECULAR TYPE OF Clostridium difficile IN NEONATAL PIGS IN AUSTRALIA

Medina- Torres C. et al.
(Weese J.S.)

O13 - PREVALENCE AND CHARACTERIZATION OF Clostridium difficile IN HORSES

Session 5           chair: Anne Collignon

 

Lapage P. et al.

L4 - HUMAN GUT MICROBIOTA: FUNCTIONALITY AND BACTERIA-HOST CROSSTALK

Kuehne S.A. et al.

O14 - THE ROLE OF TOXINS IN Clostridium difficile INFECTION

Bobo L.D. et al. (Dubberke E.R.)

O15 - MITOGEN ACTIVATED KINASE ACTIVATED PROTEIN KINASE-2 (P-MK2): RATIONALE FOR CONSIDERING THIS PROMISING BIOMARKER IN Clostridium difficile INFECTION

 

Lawley T.D. et al.

O16 - HYPERVIRULENT Clostridium difficile INDUCES INTESTINAL DYSBIOSIS TO ENHANCE TRANSMISSIBILITY

Session 6           chair: Paola Mastrantonio

 

Riley T.

L5 - CLASSICAL AND NOVEL APPROACHES IN C. difficile  DIAGNOSTICS

Tenover F.C. et al. (Baron E.J.)

O17 - IMPACT OF Clostridium difficile RIBOTYPE ON PERFORMANCE OF ANTIGEN-BASED DIAGNOSTIC ASSAYS AND RESULTS OF PCR FOR REPEATED SAMPLES ON SAME PATIENT

 

Norén T. et. al

018 - RAPID AND SENSITIVE LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) FOR Clostridium difficile DIAGNOSIS CHALLANGE CYTOTOXIN B CELL TEST AND CULTURE AS GOLD STANDARD

 

Babakhani F. et al.

O19 - KILLING KINETICS OF FIDAXOMICIN AND ITS MAJOR METABOLITE (OP-1118) VS. Clostridium difficile

Session 7           chair: Ian Poxton

Ben-Horin S.

L6 - GUT IMMUNITY

 

Spencer J. et al.

O20 - THE POTENTIAL USE OF REPEAT REGIONS IN THE BINDING DOMAINS OF TOXIN A AND TOXIN B FROM Clostridium difficile AS A VACCINE CANDIDATE

Mulvey G.L. et al. (Armstrong G.D.)

O21 - THERAPEUTIC POTENTIAL OF EGG YOLK ANTIBODIES FOR TREATING Clostridium difficile INFECTION

Tatarowicz W. et al.

O22 - SAFETY AND TOLERABILITY OF AN ORAL SUSPENSION OF VP 20621, SPORES OF A NON-TOXIGENIC C. difficile STRAIN, IN HEALTHY OLDER SUBJECTS



Posters

Banks A.

A NATIONAL SURVEILLANCE PROGRAMME FOR Clostridium difficile INFECTION (CDI) IN SCOTLAND

Boetzkes A. / Pich A.

LC-MS BASED SECRETOME ANALYSIS OF VARIOUS Clostridium difficile STRAINS

Medeiros C.A.C.X / Brito G A. C

ROLE OF THE HEME OXYGENASE/CARBON MONOXIDE PATHWAY IN  Clostridium difficile TOXIN A-INDUCED ENTERITIS IN MICE

Brown D.J./ Coia J.E.

HIERARCHICAL APPLICATION OF PCR-RIBOTYPING AND MULTILOCUS VARIABLE NUMBER TANDEM REPEAT ANALYSIS (MLVA) AS A METHOD FOR EXAMINING THE MOLECULAR EPIDEMIOLOGY OF OUTBREAKS OF Clostridium difficile INFECTIONS IN SCOTLAND

Butt E.

MODELLING RECURRENT Clostridium difficile  INFECTION THROUGH WHOLE GENOME SEQUENCING

Costa M.

THE PREVALENCE AND IMPACT OF TETRACYCLINE RESISTANCE IN Clostridium difficile IN CALVES

Drigo I.

Clostridium difficile IN LOCALLY PRODUCED SALAMI IN NORTH-EASTERN ITALY

Dubberke E.R.

COMPARISON OF Clostridium difficile DIAGNOSTIC ASSAYS WITH PROSPECTIVE PATIENTS EVALUATIONS

Rolland D. / Foussadier A.

EVALUATION OF VIDAS® C. difficile TOXIN A IgG AND VIDAS® C. difficile TOXIN B IgG PROTOTYPES ON BLOOD BANK SERA CHARACTERIZED WITH CYTOTOXICITY NEUTRALISATION ASSAY

Biazzo M. / Galeotti C. L.

DIVERSITY OF CWP LOCI IN CLINICAL ISOLATES OF Clostridium difficile

Goldenberg S.D.

SURVEY OF  ENGLISH NHS LABORATORY TESTING METHODS FOR Clostridium difficile REVEALS WIDESPREAD SUBOPTIMAL PRACTICE

Goldenberg S.D.

PREVALENCE OF BINARY TOXIN GENE AND tcdC DELETIONS AND ASSOCIATION WITH DISEASE SEVERITY IN Clostridium  difficile CLINICAL ISOLATES 2008 – 2010

Gupta S.B.

A LARGE PROSPECTIVE N. AMERICAN EPIDEMIOLOGIC STUDY OF HEALTHCARE-ASSOCIATED C.DIFFICILE COLONIZATION & INFECTION

Ito Y.

MOLECULAR EPIDEMIOLOGY OF Clostridium difficile AT A HOSPITAL IN JAPAN: SHIFTS IN THE PREDOMINANT PCR RIBOTYPE OVER A FIVE-YEAR PERIOD

Ivanova K.

PREVALENCE OF Clostridium difficile PCR RIBOTYPES IN BULGARIA  DURING AND AFTER THE PAN EUROPEAN SURVEILLANCE STUDY 2008-2010

Janezic S.

PREVALENT Clostridium difficile GENOTYPES AMONG HUMAN AND ANIMAL ISOLATES OTHER THAN RIBOTYPE 078

Jardine C. / Weese J.S.

Clostridium difficile IN WILD SMALL MAMMALS

Kim H.

CHANGES PREVALENT PCR RIBOTYPES OF Clostridium difficile IN A TERTIARY CARE KOREAN HOSPITAL OVER 10 YEARS

Louie T.J.

MICROBIOME PROFILES OF RECIPIENTS AND DONORS POST FECAL TRANSPLANTATION FOR MULTIPLY RECURRENT Clostridium difficile INFECTION

Metcalf D. / Weese J.S.

ANALYSIS OF THE Clostridium difficile BINARY TOXIN LOCUS

Metcalf D. / Weese J.S.

Clostridium difficile IN VEGETABLES AND SEAFOOD

Metcalf D. / Weese J.S.

REFERENCE GENE EVALUATION AND BINARY TOXIN GENE EXPRESSON IN Clostridium difficile

Miyajima F

Clostridium difficile INFECTION (CDI): PREDICTORS OF DISEASE SEVERITY AND DURATION OF SYMPTOMSIN A PROSPECTIVE COHORT

Mulvey M.R

THE MOLECULAR EPIDEMIOLOGY OF Clostridium difficile IN CANADIAN HOSPITALS: 2005-2009

Murillo R. / von Eichel-Streiber C.

RAPID IMMUNOCHROMATOGRAPHIC TEST TO DETECT Clostridium difficile RIBOTYPE 027 AND 017 INFECTIONS

Pirs T. / Ocepek M.

Clostridium difficile ISOLATED FROM ANIMALS: SUSCEPTIBILITY TO 30 ANTIMICROBIAL AGENTS USING BROTH MICRODILUTION METHOD

Stammler M. / Widhalm S.

MOLECULAR CHARACTERIZATION AND CLINICAL OUTCOME IN PATIENTS WITH CDAD IN AN AUSTRIAN HOSPITAL

Vohra P.

EFFICACY OF DISINFECTANTS AND DECONTAMINANTS AGAINST Clostridium difficile

Murillo R. / von Eichel-Streiber C.

RAPID IMMUNOCHROMATOGRAPHIC TEST TO DETECT Clostridium difficile RIBOTYPE 027 AND 017 INFECTIONS

Bouvet P.

GENETIC RELATEDNESS AMONG Clostridium difficile ISOLATES FROM VARIOUS ORIGINS BY TRIPLE-LOCUS SEQUENCE ANALYSIS BASED ON TOXIN REGULATORY GENES tcdC, tcdR AND cdtR

Peltier J.

AUTOLYSINS OF Clostridium difficile INVOLVED IN VEGETATIVE GROWTH

Hell M.

Clostridium difficile INFECTION IN HAEMATO-ONCOLOGIC PATIENTS - A TWO YEAR SINGLE CENTRE SURVEY

Murabata M.

INTESTINAL COLONIZATION OF Clostridium difficile IN PEDIATRIC CANCER PATIENTS AND THE CONTAMINATION OF THE WARD ENVIRONMENT WITH THIS ORGANISM

Pituch H.

DISTRIBUTION OF EPIDEMIC PCR-RIBOTYPES AND RESISTANCE TO ANTIMICROBIAL AGENTS IN Clostridium difficile ISOLATED FROM DIARRHOEIC ADULT PATIENTS HOSPITALIZED BETWEEN 2004-2008 IN THREE  HOSPITALS IN POLAND

Monot M.

RE-ANNOTATION OF THE GENOME SEQUENCE OF Clostridium difficile STRAIN 630

Permoser M. / Hell M.

Clostridium difficile INFECTION-MONOCLONAL OR POLYCLONAL ?

Uhrmann K. /Hell M.

SPOROCIDAL DISINFECTION OF THE ENVIRONMENT OF CDI-PATIENTS-AN ESSENTIAL STRATEGY FOR PREVENTION OF NOSOCOMIAL TRANSMISSION OF Clostridium difficile SPORES ?

Revathi G.

THE HOLIN LIKE PROTEIN TCDE MEDIATES Clostridium difficile TOXIN SECRETION 

Avbersek J.

COMPARISON OF A TAQMAN-BASED REAL-TIME PCR ASSAY TO A COMMERCIAL PCRFAST Clostridium difficile A/B TEST FOR DETECTION OF TOXIGENIC Clostridium difficile IN ANIMALS

Roberts P.

CHARACTERISTICS OF Clostridium difficile PCR-RIBOTYPE 027 ISOLATES AND ASSOCIATION WITH DISEASE ACTIVITY IN A LARGE HOSPITAL SETTING IN LIVERPOOL

Skraban J.

INTESTINAL MICROBIOTA IN Clostridium difficile POSITIVE AND NEGATIVE ADULT HUMANS STUDIED BY DHPLC

Thean S.

Clostridium difficile IN HORSES IN AUSTRALIA

Van Broeck J.

MOLECULAR EPIDEMIOLOGY AND ANTIMICROBIAL RESISTANCE OF Clostridium difficile ISOLATES IN BELGIUM

Van Broeck J.

A TWO STEP ALGORITHM FOR THE DIAGNOSIS OF Clostridium difficile INFECTION: SCREENING WITH A RAPID IMMUNOASSAY FOR THE DETECTION OF GLUTAMATE-DEHYDROGENASE AND TOXINS A AND B FOLLOWED BY A REAL-TIME   PCR FOR Clostridium difficile

Weese J.S.

PREVALENCE AND MOLECULAR CHARACTERIZATION OF Clostridium difficile ISOLATED FROM BEEF CATTLE UPON ARRIVAL AND EXIT FROM FEEDLOTS

Weese J.S.

PREVALENCE AND CHARACTERIZATION OF Clostridium difficile FROM SLAUGHTER-AGE PIGS

Rousseau C.

PREVALENCE AND DIVERSITY OF Clostridium difficile STRAINS IN INFANTS

Marque-Juillet S. / Le Monnier A.

DIAGNOSIS OF Clostridium difficile INFECTION IN CLINICAL LABORATORIES: A DIFFICULT COMPROMISE BETWEEN PERFORMANCE, PRACTICABILITY AND COST

Viala C. / Le Monnier A.

EVALUATION OF THREE COMMERCIALLY KITS FOR TOXIGENIC Clostridium difficile MOLECULAR DETECTION IN STOOLS

Le Monnier A.

COMPARATIVE EFFICACIES OF DAPTOMYCIN AND VANCOMYCIN FOR TREATMENT OF Clostridium difficile-ASSOCIATED DIARRHEA IN HAMSTERS

Kato H.

THE USE OF LOOP-MEDIATED ISOTHERMAL AMPLIFICATION METHOD FOR IDENTIFICATION OF Clostridium difficile PCR RIBOTYPE 027

Nazari Shirvan A.

MOLECULAR ANALYSIS OF SURFACE PROTEINS OF Clostridium difficilee4

Ammam F. / Marvaud J.C.

PREVALENCE OF THE VANG-LIKE CLUSTER IN Clostridium difficile CLINICAL ISOLATES



Contact information: icds@zzv-mb.si, fax: 00 386 2 4500 193